HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
47,000
+4,550 (10.72%)
At close: Jun 12, 2026

HEM Pharma Revenue

HEM Pharma had revenue of 4.94B KRW in the quarter ending March 31, 2026, with 40.83% growth. This brings the company's revenue in the last twelve months to 14.41B, down -9.86% year-over-year. In the year 2025, HEM Pharma had annual revenue of 12.98B, down -13.86%.

Revenue (ttm)
14.41B
Revenue Growth
-9.86%
P/S Ratio
23.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
337.28B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.98B-2.09B-13.86%
Dec 31, 202415.07B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition